Google Übersetzer
Geovax Labs Inc
About
Geovax Labs Inc (NASDAQ:GOVX) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 31 2026
GeoVax Announces a Warrant Inducement Transaction
Mar 25 2026
GeoVax Provides Update on GEO-MVA Program
Mar 12 2026
GeoVax Announces European Society of Medicine Publication Highlighting GEO-CM04S1 as a Next-Generation COVID-19 Vaccine for Immunocompromised Patients
Feb 24 2026
GeoVax Announces Oncology Advisory Board to Advance Gedeptin(R) Development Across Solid Tumors
Feb 18 2026
GeoVax Secures Exclusive License for Gedeptin(R) + Immune Checkpoint Inhibitor Combination Technology
Financials
Revenue
$3.35 M
Market Cap
$2.78 M
EPS
-31.75